Pallavi B. Limaye

1.5k total citations
15 papers, 1.1k citations indexed

About

Pallavi B. Limaye is a scholar working on Surgery, Oncology and Cell Biology. According to data from OpenAlex, Pallavi B. Limaye has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Pallavi B. Limaye's work include Pediatric Hepatobiliary Diseases and Treatments (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Liver physiology and pathology (4 papers). Pallavi B. Limaye is often cited by papers focused on Pediatric Hepatobiliary Diseases and Treatments (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Liver physiology and pathology (4 papers). Pallavi B. Limaye collaborates with scholars based in United States and Sweden. Pallavi B. Limaye's co-authors include Udayan Apte, Kartik Shankar, Vishal S. Vaidya, Harihara M. Mehendale, Curtis D. Klaassen, Youcai Zhang, Helen J. Renaud, George K. Michalopoulos, Sharmilee P. Sawant and William C. Bowen and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Pallavi B. Limaye

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pallavi B. Limaye United States 14 340 224 213 174 171 15 1.1k
Alaa E. El‐Sisi Egypt 17 312 0.9× 189 0.8× 94 0.4× 132 0.8× 82 0.5× 58 958
Μartine Aggerbeck France 25 679 2.0× 156 0.7× 122 0.6× 243 1.4× 212 1.2× 59 1.6k
Halina Cichoż‐Lach Poland 18 500 1.5× 271 1.2× 328 1.5× 659 3.8× 289 1.7× 84 1.9k
Robert E. Larson United States 18 515 1.5× 279 1.2× 143 0.7× 109 0.6× 66 0.4× 46 1.5k
Y. James Kang United States 20 486 1.4× 165 0.7× 117 0.5× 520 3.0× 74 0.4× 37 1.8k
Julie Dumont France 18 288 0.8× 142 0.6× 66 0.3× 115 0.7× 69 0.4× 30 1.2k
Steven I. Shedlofsky United States 21 354 1.0× 373 1.7× 168 0.8× 326 1.9× 91 0.5× 35 1.4k
Stacey L. Dial United States 21 544 1.6× 198 0.9× 98 0.5× 74 0.4× 72 0.4× 27 1.3k
Hrvoje Jakovac Croatia 15 269 0.8× 343 1.5× 124 0.6× 187 1.1× 42 0.2× 47 1.1k
Cristina E. Carnovale Argentina 22 468 1.4× 151 0.7× 213 1.0× 349 2.0× 218 1.3× 65 1.3k

Countries citing papers authored by Pallavi B. Limaye

Since Specialization
Citations

This map shows the geographic impact of Pallavi B. Limaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pallavi B. Limaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pallavi B. Limaye more than expected).

Fields of papers citing papers by Pallavi B. Limaye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pallavi B. Limaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pallavi B. Limaye. The network helps show where Pallavi B. Limaye may publish in the future.

Co-authorship network of co-authors of Pallavi B. Limaye

This figure shows the co-authorship network connecting the top 25 collaborators of Pallavi B. Limaye. A scholar is included among the top collaborators of Pallavi B. Limaye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pallavi B. Limaye. Pallavi B. Limaye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Czerwiński, Maciej, et al.. (2022). In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions. Pharmacology Research & Perspectives. 10(3). e00959–e00959. 15 indexed citations
2.
Czerwiński, Maciej, et al.. (2022). In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions. Pharmacology Research & Perspectives. 10(3). e00958–e00958. 16 indexed citations
3.
Zhang, Youcai, Pallavi B. Limaye, Helen J. Renaud, & Curtis D. Klaassen. (2014). Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice. Toxicology and Applied Pharmacology. 277(2). 138–145. 118 indexed citations
4.
Zhang, Youcai, Pallavi B. Limaye, Lois D. Lehman‐McKeeman, & Curtis D. Klaassen. (2012). Dysfunction of Organic Anion Transporting Polypeptide 1a1 Alters Intestinal Bacteria and Bile Acid Metabolism in Mice. PLoS ONE. 7(4). e34522–e34522. 33 indexed citations
5.
Limaye, Pallavi B., William C. Bowen, Anne Orr, Udayan Apte, & George K. Michalopoulos. (2010). Expression of hepatocytic- and biliary-specific transcription factors in regenerating bile ducts during hepatocyte-to-biliary epithelial cell transdifferentiation. PubMed. 9(1). 9–9. 23 indexed citations
6.
Limaye, Pallavi B., Gabriela Alarcón, Michael A. Nalesnik, et al.. (2008). Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development. Laboratory Investigation. 88(8). 865–872. 68 indexed citations
7.
Limaye, Pallavi B., William C. Bowen, Anne Orr, et al.. (2008). Mechanisms of hepatocyte growth factor–mediated and epidermal growth factor–mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium. Hepatology. 47(5). 1702–1713. 89 indexed citations
8.
Limaye, Pallavi B., Vishakha Bhave, Udayan Apte, et al.. (2006). Upregulation of calpastatin in regenerating and developing rat liver: Role in resistance against hepatotoxicity. Hepatology. 44(2). 379–388. 32 indexed citations
9.
Mehendale, Harihara M. & Pallavi B. Limaye. (2005). Calpain: a death protein that mediates progression of liver injury. Trends in Pharmacological Sciences. 26(5). 232–236. 66 indexed citations
10.
Corton, J. Christopher, Udayan Apte, Steven P. Anderson, et al.. (2004). Mimetics of Caloric Restriction Include Agonists of Lipid-activated Nuclear Receptors. Journal of Biological Chemistry. 279(44). 46204–46212. 88 indexed citations
11.
Sawant, Sharmilee P., Ankur V. Dnyanmote, Kartik Shankar, et al.. (2004). Potentiation of Carbon Tetrachloride Hepatotoxicity and Lethality in Type 2 Diabetic Rats. Journal of Pharmacology and Experimental Therapeutics. 308(2). 694–704. 45 indexed citations
12.
Limaye, Pallavi B., Udayan Apte, Kartik Shankar, et al.. (2003). Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants. Toxicology and Applied Pharmacology. 191(3). 211–226. 88 indexed citations
13.
Limaye, Pallavi B., et al.. (2003). 789 Expression of calpastatin and annexin I in newly divided hepatocytes: mechanism behind resistance from acute liver failure. Hepatology. 38. 541–541. 3 indexed citations
14.
Vaidya, Vishal S., Kartik Shankar, Udayan Apte, Sharmilee P. Sawant, & Pallavi B. Limaye. (2001). Introduction to Biochemical Toxicology. International Journal of Toxicology. 20(5). 331–333. 62 indexed citations
15.
Apte, Udayan, Kartik Shankar, Vishal S. Vaidya, & Pallavi B. Limaye. (2001). Principles and Methods in Toxicology. International Journal of Toxicology. 20(5). 333–335. 369 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026